Key result
Reduced and oxidized angiotensinogen display distinct monoclonal antibody binding kinetics, enabling redox state detection.
Reduced and oxidized forms of angiotensinogen exhibit different dynamic properties and binding kinetics, allowing them to be distinguished by antibody-based detection methods.
Answers are grounded in this paper and cite their sources.
Enables redox-specific angiotensinogen detection in preclinical models; leaves open clinical translation to cardiovascular disease.
Angiotensinogen fine-tunes the tightly controlled activity of the renin-angiotensin system by modulating the release of angiotensin peptides that control blood pressure. One mechanism by which this modulation is achieved is via angiotensinogen's Cys18-Cys138 disulfide bond that acts as a redox switch. Molecular dynamics simulations of each redox state of angiotensinogen reveal subtle dynamic differences between the reduced and oxidised forms, particularly at the N-terminus. Surface plasmon resonance data demonstrate that the two redox forms of angiotensinogen display different binding kinetics to an immobilised anti-angiotensinogen monoclonal antibody. Mass spectrometry mapped the epitope for the antibody to the N-terminal region of angiotensinogen. We therefore provide evidence that the different redox forms of angiotensinogen can be detected by an antibody-based detection method.
No takes yet. Share an insight, caveat, or question.
Crowther et al. (2021) studied Renin-angiotensin system regulation. Molecular dynamics simulations and surface plasmon resonance was evaluated on Binding kinetics and structural dynamics of reduced vs oxidised angiotensinogen. Reduced and oxidised forms of angiotensinogen display different dynamic properties and binding kinetics to a monoclonal antibody, allowing detection of different redox states.
Synapse has enriched 10 related papers. Consider them for comparative context: